About
Part 1: Homologous Recombination Deficiency (HRD) Detection

Originally presented at ESMO 2022

What’s New? CE-IVD Oncology Applications by SOPHiA GENETICS™​ ​
Alexander Kurze, PhD

Evaluation of a low-pass whole genome sequencing-based solution for homologous recombination deficiency detection supported by deep learning algorithms ​
Dr. Adrien Buisson
Agenda
  • What’s new? - SOPHiA DDM™​ Dx Oncology Applications
  • Evaluation of a low-pass whole genome sequencing-based solution for homologous recombination deficiency detection supported by deep learning algorithms ​
Presenters
1571226-1556610220
SOPHiA GENETICS
1665077556-caa306b6b0c877d0
Alexander Kurze, PhD
Senior Director Product Management, SOPHiA GENETICS
1665077685-291b03f3de25a147
Dr. Adrien Buisson
Praticien Spécialiste des CLCC – UF de Biologie des Tumeurs, Centre Léon Bérard- Cheney ​
Register To Watch Recording
Full name*
Email Address*
City*
Country *
Institution/Company*
Privacy Policy: By checking this box, I declare that I have read and accepted in full the SOPHiA GENETICS privacy policy. The data provided herein is used to process your request. For more information relating to our privacy policy, visit: https://www.sophiagenetics.com/privacy-policy*
By checking this box, I agree to receive information from SOPHiA GENETICS about corporate news and/or promotional communication. You will be able to unsubscribe by using the link integrated with the communication at any time.
We use BigMarker as our webinar platform. By clicking Register, you acknowledge that the information you provide will be transferred to BigMarker processing in accordance with their Terms of Service and Privacy Policy.